APA (7th ed.) Citation

Gutman, G., Barak, V., Maslovitz, S., Amit, A., Lessing, J., & Geva, E. (2005). Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor sFlt-1/VEGFR-1 but not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Fertility & Sterility, 84, S315. https://doi.org/10.1016/j.fertnstert.2005.07.825

Chicago Style (17th ed.) Citation

Gutman, G., V. Barak, S. Maslovitz, A. Amit, J.B Lessing, and E. Geva. "Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor SFlt-1/VEGFR-1 but Not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study." Fertility & Sterility 84 (2005): S315. https://doi.org/10.1016/j.fertnstert.2005.07.825.

MLA (9th ed.) Citation

Gutman, G., et al. "Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor SFlt-1/VEGFR-1 but Not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study." Fertility & Sterility, vol. 84, 2005, p. S315, https://doi.org/10.1016/j.fertnstert.2005.07.825.